New!
Portfolio
Login
/
Sign Up
Search
Industries
Technology
Energy
Media
Finance
Green Issues
China
All Concepts
Metals
Energy
Meats
Grains
Softs
ETFs
Indices
Currencies
Geographies
Exchanges
Rates
How To Invest
Personal Finance
Options 101
Definitions
close
close
close
close
Send us Feedback
Teva Pharmaceutical Industries (TEVA)
SUMMARY
BULLS
BEARS
TOPICS
DATA CENTRAL
STOCK CHART
SEC FILINGS
BALANCE
INCOME
CASH FLOW
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
Cash Flow Statement (USD)
Annual
|
Quarterly
QUARTER ENDING
31-MAR
2012
30-JUN
2012
30-SEP
2012
31-DEC
2012
31-MAR
2013
Net Income
871M
875M
-71.0M
334M
650M
Depreciation
519M
384M
412M
393M
-1.32B
Amortization
0
0
0
0
0
Deferred Taxes
-406M
95.0M
-192M
-187M
590M
Change In Working Capital
-878M
-64.0M
475M
284M
-354M
Other Non Cash Operating Items
-700M
-83.0M
437M
807M
-1.10B
Cash From Operations
-3.38B
1.19B
1.05B
1.58B
-3.47B
Capital Expenditures
-274M
-254M
-249M
-327M
840M
Sale of Assets
126M
7.00M
67.0M
64.0M
-121M
Acquisitions
0
0
0
0
0
Investments
-8.00M
-17.0M
-48.0M
-128M
97.0M
Other Investing Activities
7.29B
-272M
-268M
-345M
892M
Cash from Investing
7.41B
-282M
-249M
-409M
868M
Dividends Paid
-174M
-230M
-237M
-214M
574M
Sale / Purchase of Stock
-521M
-127M
5.00M
-504M
949M
Net Borrowings
82.0M
1.80B
-31.0M
-2.83B
-790M
Other Financing Cash Flows
-3.34B
-2.21B
-307M
3.81B
-1.31B
Cash From Financing
-3.95B
-761M
-570M
266M
-582M
Foreign Exchange Effect
38.0M
-22.0M
15.0M
13.0M
-84.0M
Net Change in Cash
118M
126M
244M
1.45B
-3.27B
Add Metric
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
Bet you've never seen portfolio analytics like these.
Introducing
SigFig
— from the creators of
Take Tour